10x Genomics (TXG) Retained Earnings (2018 - 2025)
Historic Retained Earnings for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to -$1.5 billion.
- 10x Genomics' Retained Earnings fell 296.81% to -$1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.5 billion, marking a year-over-year decrease of 296.81%. This contributed to the annual value of -$1.5 billion for FY2025, which is 296.81% down from last year.
- 10x Genomics' Retained Earnings amounted to -$1.5 billion in Q4 2025, which was down 296.81% from -$1.5 billion recorded in Q3 2025.
- Over the past 5 years, 10x Genomics' Retained Earnings peaked at -$816.6 million during Q1 2021, and registered a low of -$1.5 billion during Q4 2025.
- In the last 5 years, 10x Genomics' Retained Earnings had a median value of -$1.2 billion in 2023 and averaged -$1.2 billion.
- Per our database at Business Quant, 10x Genomics' Retained Earnings crashed by 18804.95% in 2021 and then crashed by 296.81% in 2025.
- 10x Genomics' Retained Earnings (Quarter) stood at -$863.3 million in 2021, then dropped by 19.23% to -$1.0 billion in 2022, then fell by 24.78% to -$1.3 billion in 2023, then decreased by 14.22% to -$1.5 billion in 2024, then decreased by 2.97% to -$1.5 billion in 2025.
- Its Retained Earnings was -$1.5 billion in Q4 2025, compared to -$1.5 billion in Q3 2025 and -$1.5 billion in Q2 2025.